Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CCN009: A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate the Effects on the Mechanisms of Contraceptive Efficacy and, Secondarily, to Assess the Pharmacokinetic Profile and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)

NCT01166412 is registered in ClinicalTrials.gov with Premier Research as lead sponsor.

NCT NCT01166412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01166412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CCN009: A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate the Effects on the Mechanisms of Contraceptive Efficacy and, Secondarily, to Assess the Pharmacokinetic Profile and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)
Lead sponsor
Premier Research
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2010
Completion date
July 31, 2012
Enrollment
121 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

contraception